Lurasidone hydrochloride ( —— )

Catalog No. M14263 CAS No. 367514-88-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

Lurasidone hydrochloride
Note

Research use only, not for human use.
Brief Description

Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma.
Description

Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States.
Synonyms

——
Pathway

Endocrinology/Hormones
Target

5-HT Receptor
Recptor

5-HT1A; 5-HT2A; 5-HT7; D2; Norepinephrine α2C
Research Area

Neurological Disease
Indication

——

CAS Number

367514-88-3
Formula Weight

529.14
Molecular Formula

C28H36N4O2S·HCl
Purity

>98%(HPLC)
Solubility

DMSO: 1 mg/mL (1.88 mM)
SMILES

C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O.Cl
Chemical Name

——

1.Murai T, et al. Behav Brain Res. 2014 Mar 15;261:26-30.

Calculator

molnova catalog